Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)
-
-
PWY-7726
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,4-dichlorobenzene degradation
-
-
14DICHLORBENZDEG-PWY
11-oxyandrogens biosynthesis
-
-
PWY-8202
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)
-
-
PWY-6362
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza)
-
-
PWY-4661
1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium)
-
-
PWY-6372
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)
-
-
PWY-6554
2-amino-3-hydroxycyclopent-2-enone biosynthesis
-
-
PWY-7536
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
2-deoxy-D-ribose degradation II
-
-
PWY-8058
2-oxobutanoate degradation I
-
-
PWY-5130
3,4,6-trichlorocatechol degradation
-
-
PWY-6094
3,5-dichlorocatechol degradation
-
-
PWY-6084
3-chlorocatechol degradation
-
-
3-chlorocatechol degradation I (ortho)
-
-
PWY-6089
3-chlorocatechol degradation II (ortho)
-
-
PWY-6193
3-hydroxypropanoate cycle
-
-
PWY-5743
3-hydroxypropanoate/4-hydroxybutanate cycle
-
-
PWY-5789
3-phosphoinositide biosynthesis
-
-
PWY-6352
4,5-dichlorocatechol degradation
-
-
PWY-6093
4-aminobutanoate degradation I
-
-
PWY-6535
4-aminobutanoate degradation II
-
-
PWY-6537
4-aminobutanoate degradation III
-
-
PWY-6536
4-aminobutanoate degradation V
-
-
PWY-5022
4-chlorocatechol degradation
-
-
PWY-6087
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
5-oxo-L-proline metabolism
-
-
PWY-7942
ABH and Lewis epitopes biosynthesis from type 1 precursor disaccharide
-
-
PWY-7832
Alanine, aspartate and glutamate metabolism
-
-
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
Amino sugar and nucleotide sugar metabolism
-
-
ammonia assimilation cycle III
-
-
AMMASSIM-PWY
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anandamide degradation
-
-
PWY6666-1
anandamide lipoxygenation
-
-
PWY-8056
androgen and estrogen metabolism
-
-
androgen biosynthesis
-
-
PWY66-378
anteiso-branched-chain fatty acid biosynthesis
-
-
PWY-8173
apratoxin A biosynthesis
-
-
PWY-8361
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arachidonic acid metabolism
-
-
arachidonic acid metabolism
-
-
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
backdoor pathway of androgen biosynthesis
-
-
PWY-8200
beta-alanine biosynthesis II
-
-
PWY-3941
beta-Alanine metabolism
-
-
Biosynthesis of secondary metabolites
-
-
Biosynthesis of unsaturated fatty acids
-
-
butanoate fermentation
-
-
C4 and CAM-carbon fixation
-
-
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
C4 photosynthetic carbon assimilation cycle, NADP-ME type
-
-
PWY-241
C4 photosynthetic carbon assimilation cycle, PEPCK type
-
-
PWY-7117
caffeine degradation III (bacteria, via demethylation)
-
-
PWY-6538
camalexin biosynthesis
-
-
CAMALEXIN-SYN
Carbon fixation in photosynthetic organisms
-
-
Carbon fixation pathways in prokaryotes
-
-
CDP-diacylglycerol biosynthesis
-
-
CDP-diacylglycerol biosynthesis I
-
-
PWY-5667
CDP-diacylglycerol biosynthesis II
-
-
PWY0-1319
cell-surface glycoconjugate-linked phosphocholine biosynthesis
-
-
PWY-7886
ceramide biosynthesis
-
-
ceramide de novo biosynthesis
-
-
PWY3DJ-12
Chlorocyclohexane and chlorobenzene degradation
-
-
cholesterol biosynthesis
-
-
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
choline biosynthesis I
-
-
PWY-3385
choline biosynthesis III
-
-
PWY-3561
Citrate cycle (TCA cycle)
-
-
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)
-
-
PWY-6138
CO2 fixation into oxaloacetate (anaplerotic)
-
-
PWYQT-4429
coenzyme A metabolism
-
-
complex N-linked glycan biosynthesis (vertebrates)
-
-
PWY-7426
creatine biosynthesis
-
-
GLYCGREAT-PWY
curacin A biosynthesis
-
-
PWY-8358
Cutin, suberine and wax biosynthesis
-
-
cylindrospermopsin biosynthesis
-
-
PWY-8045
Cysteine and methionine metabolism
-
-
D-Amino acid metabolism
-
-
D-arabinose degradation V
-
-
PWY-8334
D-galactose degradation IV
-
-
PWY-6693
D-myo-inositol (1,4,5)-trisphosphate biosynthesis
-
-
PWY-6351
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6366
D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6365
D-myo-inositol-5-phosphate metabolism
-
-
PWY-6367
detoxification of reactive carbonyls in chloroplasts
-
-
PWY-6786
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
diacylglycerol and triacylglycerol biosynthesis
-
-
TRIGLSYN-PWY
docosahexaenoate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7606
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichol and dolichyl phosphate biosynthesis
Drug metabolism - cytochrome P450
-
-
Drug metabolism - other enzymes
-
-
ergothioneine biosynthesis I (bacteria)
-
-
PWY-7255
Ether lipid metabolism
-
-
even iso-branched-chain fatty acid biosynthesis
-
-
PWY-8175
Fatty acid biosynthesis
-
-
fatty acid biosynthesis initiation (type I)
-
-
PWY-5966-1
Fatty acid degradation
-
-
ferrichrome A biosynthesis
-
-
PWY-7571
Fluorobenzoate degradation
-
-
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
fructose 2,6-bisphosphate biosynthesis
-
-
PWY66-423
Fructose and mannose metabolism
-
-
GABA shunt I
-
-
GLUDEG-I-PWY
GABA shunt II
-
-
PWY-8346
gamma-glutamyl cycle
-
-
PWY-4041
gamma-linolenate biosynthesis II (animals)
-
-
PWY-6000
ganglio-series glycosphingolipids biosynthesis
-
-
PWY-7836
ginkgotoxin biosynthesis
-
-
PWY-8077
gliotoxin biosynthesis
-
-
PWY-7533
globo-series glycosphingolipids biosynthesis
-
-
PWY-7838
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
Glucosinolate biosynthesis
-
-
glutamate and glutamine metabolism
-
-
glutaminyl-tRNAgln biosynthesis via transamidation
-
-
PWY-5921
glutathione biosynthesis
-
-
GLUTATHIONESYN-PWY
Glutathione metabolism
-
-
glutathione metabolism
-
-
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glycerol-3-phosphate shuttle
-
-
PWY-6118
Glycerolipid metabolism
-
-
Glycerophospholipid metabolism
-
-
glycine betaine degradation I
-
-
PWY-3661
glycine betaine degradation II (mammalian)
-
-
PWY-3661-1
Glycine, serine and threonine metabolism
-
-
Glycosphingolipid biosynthesis - ganglio series
-
-
Glycosphingolipid biosynthesis - globo and isoglobo series
-
-
Glycosphingolipid biosynthesis - lacto and neolacto series
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate assimilation
-
-
PWY-5744
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
guadinomine B biosynthesis
-
-
PWY-7693
heme degradation I
-
-
PWY-5874
histamine biosynthesis
-
-
PWY-6173
homocysteine and cysteine interconversion
-
-
PWY-801
homoglutathione biosynthesis
-
-
PWY-6840
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
icosapentaenoate biosynthesis II (6-desaturase, mammals)
-
-
PWY-7049
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
Inositol phosphate metabolism
-
-
isoleucine metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
ketogenesis
-
-
PWY66-367
L-alanine biosynthesis I
-
-
ALANINE-VALINESYN-PWY
L-arabinose degradation II
-
-
PWY-5515
L-arginine biosynthesis I (via L-ornithine)
-
-
ARGSYN-PWY
L-arginine biosynthesis II (acetyl cycle)
-
-
ARGSYNBSUB-PWY
L-arginine biosynthesis IV (archaea)
-
-
PWY-7400
L-arginine degradation XIII (reductive Stickland reaction)
-
-
PWY-8187
L-arginine degradation XIV (oxidative Stickland reaction)
-
-
PWY-6344
L-asparagine biosynthesis III (tRNA-dependent)
-
-
PWY490-4
L-citrulline biosynthesis
-
-
CITRULBIO-PWY
L-citrulline degradation
-
-
CITRULLINE-DEG-PWY
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-cysteine biosynthesis VI (reverse transsulfuration)
-
-
PWY-I9
L-glutamate biosynthesis I
-
-
GLUTSYN-PWY
L-glutamine degradation I
-
-
GLUTAMINDEG-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine biosynthesis V
-
-
PWY-5108
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-isoleucine degradation III (oxidative Stickland reaction)
-
-
PWY-8184
L-leucine biosynthesis
-
-
LEUSYN-PWY
L-leucine degradation I
-
-
LEU-DEG2-PWY
L-leucine degradation III
-
-
PWY-5076
L-leucine degradation IV (reductive Stickland reaction)
-
-
PWY-7767
L-leucine degradation V (oxidative Stickland reaction)
-
-
PWY-8185
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-lysine degradation II (L-pipecolate pathway)
-
-
PWY66-425
L-lysine degradation V
-
-
PWY-5283
L-lysine degradation XI
-
-
LYSINE-DEG1-PWY
L-methionine degradation I (to L-homocysteine)
-
-
METHIONINE-DEG1-PWY
L-methionine salvage from L-homocysteine
-
-
ADENOSYLHOMOCYSCAT-PWY
L-threonine degradation V
-
-
PWY66-428
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation I
-
-
VALDEG-PWY
L-valine degradation II
-
-
PWY-5057
L-valine degradation III (oxidative Stickland reaction)
-
-
PWY-8183
lacto-series glycosphingolipids biosynthesis
-
-
PWY-7839
leukotriene biosynthesis
-
-
PWY66-375
linoleate metabolites biosynthesis
-
-
PWY-8395
Linoleic acid metabolism
-
-
lipoxin biosynthesis
-
-
PWY66-392
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
maresin biosynthesis
-
-
PWY-8356
metabolism of amino sugars and derivatives
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
methionine metabolism
-
-
methylglyoxal degradation III
-
-
PWY-5453
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
Microbial metabolism in diverse environments
-
-
mixed acid fermentation
-
-
FERMENTATION-PWY
monoacylglycerol metabolism (yeast)
-
-
PWY-7420
N-acetylneuraminate and N-acetylmannosamine degradation I
-
-
PWY0-1324
N-Glycan biosynthesis
-
-
neolacto-series glycosphingolipids biosynthesis
-
-
PWY-7841
Nicotinate and nicotinamide metabolism
-
-
nicotine degradation I (pyridine pathway)
-
-
P181-PWY
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
Nitrotoluene degradation
-
-
odd iso-branched-chain fatty acid biosynthesis
-
-
PWY-8174
oleate beta-oxidation
-
-
PWY0-1337
oleate biosynthesis III (cyanobacteria)
-
-
PWY-7587
ophthalmate biosynthesis
-
-
PWY-8043
Other types of O-glycan biosynthesis
-
-
palmitate biosynthesis I (type I fatty acid synthase)
-
-
PWY-5994
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
Pantothenate and CoA biosynthesis
-
-
pentachlorophenol degradation
-
-
PCPDEG-PWY
Pentose and glucuronate interconversions
-
-
Pentose phosphate pathway
-
-
pentose phosphate pathway
-
-
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phosphatidylcholine biosynthesis I
-
-
PWY3O-450
phosphatidylcholine biosynthesis II
-
-
PWY4FS-2
phosphatidylcholine biosynthesis III
-
-
PWY4FS-3
phosphatidylcholine biosynthesis IV
-
-
PWY4FS-4
phosphatidylcholine biosynthesis V
-
-
PWY-6825
phosphatidylethanolamine bioynthesis
-
-
phospholipases
-
-
LIPASYN-PWY
Phosphonate and phosphinate metabolism
-
-
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
phosphopantothenate biosynthesis II
-
-
PWY-3961
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
Porphyrin and chlorophyll metabolism
-
-
Primary bile acid biosynthesis
-
-
procollagen hydroxylation and glycosylation
-
-
PWY-7894
Propanoate metabolism
-
-
protectin biosynthesis
-
-
PWY-8357
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
pyridoxal 5'-phosphate salvage II (plants)
-
-
PWY-7204
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
Pyrimidine metabolism
-
-
pyrimidine metabolism
-
-
pyruvate fermentation to propanoate I
-
-
P108-PWY
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinoate biosynthesis I
-
-
PWY-6872
S-adenosyl-L-methionine salvage II
-
-
PWY-5041
Selenocompound metabolism
-
-
selenocysteine biosynthesis
-
-
spermine biosynthesis
-
-
ARGSPECAT-PWY
sphingolipid biosynthesis (mammals)
-
-
PWY-7277
sphingolipid biosynthesis (plants)
-
-
PWY-5129
Sphingolipid metabolism
-
-
sphingomyelin metabolism
-
-
PWY3DJ-11281
Starch and sucrose metabolism
-
-
Steroid hormone biosynthesis
-
-
stigma estolide biosynthesis
-
-
PWY-6453
superpathway of coenzyme A biosynthesis III (mammals)
-
-
COA-PWY-1
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of polyamine biosynthesis II
-
-
POLYAMINSYN3-PWY
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VIII (Chlamydia)
-
-
TCA-1
terminal O-glycans residues modification (via type 2 precursor disaccharide)
-
-
PWY-7434
Terpenoid backbone biosynthesis
-
-
testosterone and androsterone degradation to androstendione (aerobic)
-
-
PWY-6943
tetrapyrrole biosynthesis I (from glutamate)
-
-
PWY-5188
tetrapyrrole biosynthesis II (from glycine)
-
-
PWY-5189
theophylline degradation
-
-
PWY-6999
thymine degradation
-
-
PWY-6430
triacylglycerol degradation
-
-
LIPAS-PWY
Tryptophan metabolism
-
-
tryptophan metabolism
-
-
type IV lipoteichoic acid biosynthesis (S. pneumoniae)
-
-
PWY-7818
uracil degradation I (reductive)
-
-
PWY-3982
UTP and CTP dephosphorylation I
-
-
PWY-7185
UTP and CTP dephosphorylation II
-
-
PWY-7177
Valine, leucine and isoleucine biosynthesis
-
-
Valine, leucine and isoleucine degradation
-
-
valproate beta-oxidation
-
-
PWY-8182
Various types of N-glycan biosynthesis
-
-
Vitamin B6 metabolism
-
-
zymosterol biosynthesis
-
-
PWY-6074
cyanate degradation
-
-
CYANCAT-PWY
dolichol and dolichyl phosphate biosynthesis
-
-
PWY-6129
dolichol and dolichyl phosphate biosynthesis
-
-
methylaspartate cycle
-
-
PWY-6728
methylaspartate cycle
-
-
urea cycle
-
-
PWY-4984
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
thorax
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
primary culture
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
of bone marrow
brenda
-
-
brenda
-
-
brenda
-
leg muscle
brenda
-
-
brenda
-
-
brenda
-
granuloma pouch model of granulation tissue, organ culture
brenda
-
-
brenda
-
-
brenda
-
expression of MMP-8 does not change significantly in ovariectomized rat
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
mucosa, urothelium, no FAAH immunoreactivity in other structures of the bladder
brenda
-
in the urine of the fatigued rats, the ALA level increases (approximately 2fold) as compared with that of the control rats
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
cells in the vascular external layer
brenda
-
-
brenda
-
epididymal fat pads
brenda
-
-
brenda
-
arteries from hypertensive rats, vascular PDE1A, PDE1B, PDE1C, and PDE5 isoforms
brenda
-
PDE 1 vascular expression is increased in arteries from angiotensin II hypertensive rats
brenda
-
PDE5 vascular expression is decreased in arteries from angiotensin II hypertensive rats compared to control rats
brenda
-
-
brenda
-
primary cortical astrocyte cultures
brenda
-
transcriptional regulation of ACE2 mRNA in astrocytes is dependent on the relative concentrations of both angiotensin II and angiotensin(17) as well as on interaction with their respective receptors
brenda
-
-
brenda
-
plasma ALA level of the fatigued rats is slightly higher (approximately 1.4fold) than that of the control or food-restricted animals
brenda
-
-
brenda
-
amoeboid microglial cells in the postnatal rat brain
brenda
-
from male rats
brenda
-
in all parts of the brain
brenda
-
in situ and in vitro enzymatic activity of transglutaminase isoforms on brain tissue sections and brain extract, monitoring of differences in post-translational protein modifications during neurodegeneration, overview. TG6 shows only a faint vascular signal as compared to a prominent cellular staining in rat tissue
brenda
-
increased expression of 12/15-LOX, predominantly in neurons, and elevated production of 12(S)-hydroperoxyicosatetraenoate and 15(S)-hydroperoxyicosatetraenoate in ischemic brain
brenda
-
proteasome composition in brain, overview
brenda
-
the distributions of H3-K4 mono-, di-, and tri-methylated histones exhibit exactly the same pattern as the LSD1 protein, immunofluoresecence histochemic analysis, overview
brenda
-
transcriptional regulation of ACE2 mRNA in astrocytes is dependent on the relative concentrations of both angiotensin II and angiotensin(17) as well as on interaction with their respective receptors
brenda
-
-
brenda
-
cerebrum shows higher activity than cerebellum
brenda
-
-
brenda
-
primary
brenda
-
-
brenda
-
high expression level
brenda
-
-
brenda
-
enzyme activity is significantly elevated at 8 h after intradermal injection of carageenan or urate crystals, falling to normal levels by day 3
brenda
-
-
brenda
-
portal fibroblasts
brenda
-
coeliac ganglia
brenda
-
superior cervical ganglia
brenda
-
-
brenda
-
heart isozyme PFKFB2
brenda
-
left ventricle
brenda
-
sarcolemma, sarcolemmal vesicles
brenda
-
ventricular muscle
brenda
-
very low level
brenda
-
-
brenda
-
primary
brenda
-
primary hepatocytes
brenda
-
restricted to the canalicular membrane domain of hepatocytes
brenda
-
-
brenda
-
activity in colonic tissue is 25-50times lower than in liver
brenda
-
activity is 20fold lower in colonic mucosa than in liver
brenda
-
colonic mucosa: normal mucosa, non-malignant mucosa in azomethane treated animals, low activity in azomethane-induced tumor tissue
brenda
-
enzyme activity is equal to or only 2fold lower than in liver
brenda
-
normal, non-malignant. Low activity in tumour cells
brenda
-
-
brenda
-
jejunal sucrase-isomaltase gene is induced during postnatal development
brenda
-
-
brenda
-
inner medullary collecting ducts, proteomic analysis of the cytoplasmic fraction of inner medullary collecting ducts, overview
brenda
-
renal cortex
brenda
-
-
brenda
-
distribution of the enzyme
brenda
-
effects of gender on hepatic enzyme activity, overview
brenda
-
enzyme activity is significantly elevated at 8 h after intradermal injection of carrageenan or urate crystals, falling to normal levels by day 3
brenda
-
expression of isozymes NTPDase1, -2, and -8 in distinct liver compartments in normal and fibrotic rat liver
brenda
-
HMG-CoA reductase activity is higher in both female and male Nagase analbumimetic rats than in Sprague-Dwwley rats. Ovariectomy results in no significant changes in total hepatic HMG-CoA reductase in female Sprague-Dawley rats
brenda
-
less than 20% activity compared to brain extracts
brenda
-
low level
brenda
-
lowest enzyme activity
brenda
-
modified HMG-CoA reductase and low density lipoprotein receptor regulation is deeply involved in age-related hypercholesterolemia
brenda
-
non-inducible
brenda
-
of type 1 diabetic rats
brenda
-
phenobarbital-treated animals
brenda
-
predominant
brenda
-
predominantly
brenda
-
-
brenda
-
high enzyme content
brenda
-
highest enzyme activity
brenda
-
-
brenda
-
alveolar macrophages purified from the lung by lavage, and interstitial macrophages. Inflammatory cells express high levels of XOR activity, while in resident alveolar macrophage the enzyme content is extremely low prior to cytokine insufflation
brenda
-
-
brenda
-
endogenous GPX4 is mainly expressed in neurons, usage of primary cultured cortical neurons
brenda
-
hippocampal
brenda
-
hippocampal and cortical
brenda
-
neurons of the tuberomammillary nucleus of the posterior hypothalamus
brenda
-
nitrergic neurons in the rat stomach, the myenteric cell bodies have single axons, type I morphology and a wide range of sizes. Nitrergic terminals do not provide baskets of terminals around myenteric neurons. The nitrergic neuron populations in the stomach supply the muscle layers and intramural arteries, but, unlike in the intestine, gastric interneurons do not express nNOS
brenda
-
primary cortical neuronal cultures
brenda
-
primary cortical neurons, increased expression of 12/15-LOX, predominantly in neurons, and elevated production of 12(S)-hydroperoxyicosatetraenoate and 15(S)-hydroperoxyicosatetraenoate in ischemic brain
brenda
-
primary culture
brenda
-
primary sympathetic and cultured primary, isozyme CTbeta2 mRNA and protein are abundant in distal axons of mouse sympathetic neurons, whereas isozyme CTalpha mRNA and protein are not detected
brenda
-
striatal, from neonatal rats
brenda
-
-
brenda
-
inducible
brenda
-
-
brenda
-
enzyme content decreases 0.7fold after running exercise for 5 weeks
brenda
-
soleus muscle
brenda
-
soleus slow-twitch oxidative, RG, red gastrocnemius fast-twitch oxidative glycolytic, and WG, white gastrocnemius fast-twitch glycolytic muscles
brenda
-
-
brenda
-
highest enzyme activity
brenda
-
-
brenda
-
beta-naphtoflavone-treated animals
brenda
-
-
brenda
-
low level
brenda
-
-
brenda
-
nitrergic neurons in the rat stomach comprising similar proportions of myenteric neurons, about 30%, in all gastric regions, e.g. the longitudinal, circular and oblique layers of the external muscle, the muscularis mucosae and arteries within the gastric wall
brenda
additional information
-
-
brenda
additional information
-
a higher proportion of doubly-capped 26S proteasome (19S-20S-19S) in the brain cortex than in the liver or kidney
brenda
additional information
-
BCKD protein expression is higher in primarily cultured cortical neurons than in astrocytes, whereas pBCKD protein level is higher in astrocytes than in cortical neurons
brenda
additional information
-
determination of NADPH diaphorase staining in preganglionic terminals, staining generally ascribed to NADH diaphorase activity in aldehyde-treated tissues
brenda
additional information
-
distribution in different tissues
brenda
additional information
-
enzyme activity in rats of different strains and with different sexes, the enzyme is upregulated in both female and male Nagase analbuminemic rats compared to Sprague-Dawley rats, overview
brenda
additional information
-
enzyme tissue localization by in situ immunohistochemistry, overview
brenda
additional information
-
immunohistochemic enzyme and NADPH histochemic analysis, distributions of nNOS neurons and their terminals throughout the rat stomach, overview. NADPH diaphorase is the colour reaction that reveals the presence of NADPH oxidases, and because nNOS is a NADPH oxidase, it is revealed by NADPHd histochemistry
brenda
additional information
-
immunolocalization of histamine, with rabbit anti-L-histidine decarboxylase (HDC) antiserum, within the tuberomammillary nucleus is validated using carbodiimide. Rapid eye movement sleep deprivation (REM-SD) increases immunoreactive L-histidine decarboxylase by day 5, and it remains elevated in both dorsal and ventral aspects of the tuberomammillary complex
brenda
additional information
-
light-driven translocation of PIPKIIalpha from the rod inner segment to rod outer segment, and subsequent binding to the ROS membrane
brenda
additional information
-
no glutamine transaminase activity in skeletal muscle, testis, spleen, pancreas, lung and intestine
brenda
additional information
-
not in leukocytes and ascites tumor cells
brenda
additional information
-
TG6 expression seems to localize to neurons but not to astrocytes or microglia
brenda
additional information
-
the enzyme activity decreases with age in all the tissues studied
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.